Paul Chinn

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.

Susan J. Knox, Michael L. Goris, Kirk Trisler et al. · PubMed · 1996 · 332 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +14

Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma.

Paul Chinn, John E. Leonard, J. Rosenberg et al. · International Journal of Oncology · 1999 · 91 citations

Immunology, Immunophenotyping, Immunotherapeutics +17

Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions

Mario I. Vega, Sara Huerta‐Yépez, Melisa Martinez-Paniagua et al. · Clinical Cancer Research · 2009 · 60 citations · Full text

In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain

Takehiko Nakamura, William S. Kloetzer, Peter Brams et al. · International Journal of Immunopharmacology · 2000 · 48 citations

Immunoglobulin Fc Domain, Autoimmune Disease, Vitro Ige Inhibition +11

Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells<b><i>in vitro</i></b>via hyperthermia

Jianping Zhang, Abiche H. Dewilde, Paul Chinn et al. · International Journal of Hyperthermia · 2011 · 41 citations